Stereotaxis Statistics
Total Valuation
Stereotaxis has a market cap or net worth of $251.36 million. The enterprise value is $249.21 million.
Important Dates
The next estimated earnings date is Monday, November 10, 2025, after market close.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Stereotaxis has 91.07 million shares outstanding. The number of shares has increased by 4.54% in one year.
| Current Share Class | 91.07M |
| Shares Outstanding | 91.07M |
| Shares Change (YoY) | +4.54% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 11.53% |
| Owned by Institutions (%) | 30.97% |
| Float | 63.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.64 |
| Forward PS | 5.96 |
| PB Ratio | 164.80 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.85.
| Current Ratio | 1.06 |
| Quick Ratio | 0.55 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -198.62% and return on invested capital (ROIC) is -78.31%.
| Return on Equity (ROE) | -198.62% |
| Return on Assets (ROA) | -35.03% |
| Return on Invested Capital (ROIC) | -78.31% |
| Return on Capital Employed (ROCE) | -105.89% |
| Revenue Per Employee | $228,820 |
| Profits Per Employee | -$177,252 |
| Employee Count | 139 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 1.68 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.61% in the last 52 weeks. The beta is 1.61, so Stereotaxis's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | +26.61% |
| 50-Day Moving Average | 2.57 |
| 200-Day Moving Average | 2.23 |
| Relative Strength Index (RSI) | 51.16 |
| Average Volume (20 Days) | 370,379 |
Short Selling Information
The latest short interest is 2.99 million, so 3.28% of the outstanding shares have been sold short.
| Short Interest | 2.99M |
| Short Previous Month | 3.98M |
| Short % of Shares Out | 3.28% |
| Short % of Float | 4.69% |
| Short Ratio (days to cover) | 5.36 |
Income Statement
In the last 12 months, Stereotaxis had revenue of $31.81 million and -$24.64 million in losses. Loss per share was -$0.29.
| Revenue | 31.81M |
| Gross Profit | 15.96M |
| Operating Income | -21.63M |
| Pretax Income | -19.87M |
| Net Income | -24.64M |
| EBITDA | -20.17M |
| EBIT | -21.63M |
| Loss Per Share | -$0.29 |
Full Income StatementBalance Sheet
The company has $6.97 million in cash and $5.73 million in debt, giving a net cash position of $1.24 million or $0.01 per share.
| Cash & Cash Equivalents | 6.97M |
| Total Debt | 5.73M |
| Net Cash | 1.24M |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | 6.75M |
| Book Value Per Share | 0.02 |
| Working Capital | 1.16M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.58 million and capital expenditures -$35,000, giving a free cash flow of -$8.61 million.
| Operating Cash Flow | -8.58M |
| Capital Expenditures | -35,000 |
| Free Cash Flow | -8.61M |
| FCF Per Share | -$0.09 |
Full Cash Flow StatementMargins
Gross margin is 50.17%, with operating and profit margins of -68.00% and -73.43%.
| Gross Margin | 50.17% |
| Operating Margin | -68.00% |
| Pretax Margin | -73.43% |
| Profit Margin | -73.43% |
| EBITDA Margin | -63.40% |
| EBIT Margin | -68.00% |
| FCF Margin | n/a |
Dividends & Yields
Stereotaxis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.54% |
| Shareholder Yield | -4.54% |
| Earnings Yield | -9.84% |
| FCF Yield | -3.44% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 11, 2012. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
Stereotaxis has an Altman Z-Score of -17.29 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.29 |
| Piotroski F-Score | 2 |
